Best Online Semaglutide Compounding Pharmacies Compared For 2026

Quick Picks: Five Providers Ranked on Operational Quality

Not all compounded semaglutide platforms have the same standards. Some of the better ones will publicly list their dispensing pharmacy, who is overseeing patient care, and what quality standards they go by.

Some telehealth companies may use broad language about sourcing from 503B facilities or meeting USP <797> standards. However, semaglutide is no longer on the FDA’s shortage list^[3] and is not on the 503B bulk drugs list^[4], which means there may be a lack of legal clarity for compounding it this way.

What We Considered When Ranking Semaglutide Compounding Providers

Our team evaluated each provider across five operational pillars. The condensed criteria are below — for the full methodology, jump to our complete ranking criteria.

1. Pharmacy Quality & Accreditation — FDA-registered facility, PCAB or comparable accreditation, named dispensing pharmacy.
2. API Sourcing & Testing — Documented active-ingredient source plus batch-level potency, purity, and sterility testing.
3. Level of Clinical Oversight — Named medical director, licensed prescribers, and clear titration protocols.
4. Transparency & Pricing — Upfront pricing, no hidden membership fees, and clear what’s-included disclosures.
5. Cancellation & Continuity — Straightforward cancellation, refund policy, and a path to switch providers without restarting.

Read Our Full Ranking Criteria →

Semaglutide Compounding Pharmacy Reviews: A Detailed Look

How the Five Providers Stack Up

With evolving regulatory changes in the compounded semaglutide space, it can be hard to get clear on the best telehealth platform or provider. Although some of the five providers discussed in this article have publicly disclosed dispensing pharmacies, this information is not always upfront. In addition, none of the providers publicly commits to a semaglutide salt form, and Certificates of Analysis are not automatic at any provider. Here’s where we’ve narrowed down the results.

Noom Med (9.6): Named doctors and coaching built in. Noom is one of the only providers here that publicly names its Chief Medical Officer (Dr. Egler) and Chief of Medicine, and it owns its dispensing pharmacy, Tailor Made Compounding. Although the pharmacy has a disciplinary history, nothing new has come up in recent times.

OnlineSemaglutide.org (9.4): Transparent pharmacy and prescriber network. OnlineSemaglutide.org is the only provider here that publicly names all four of its partner compounding pharmacies (Belmar, Strive, Epiq Scripts, and Casa Pharma Rx) and lists three NPI-verifiable prescribers on its About page. The trade-off is age: it launched in June 2025, so there’s no Trustpilot or BBB track record yet.

Henry Meds (9.3): Clear regulatory framing. Henry is one of the most upfront providers about how its prescriptions are filled, mentioning both 503A and 503B compounding pharmacies and linking clinical care to a named medical group (Colchis Medical Services PC). The main gap is that the actual pharmacy filling your order isn’t named on the site. Ask for it in writing before you order.

Shed (8.6): Most product options, but do your homework. Shed offers various formats, including injections, tablets, lozenges, and drops. The catch is that only the injection has substantial clinical research behind it. Two of Shed’s three known pharmacy partners (Strive and Promise Pharmacy) have had disciplinary actions from the FDA in the past, with one citation linked directly to semaglutide compounding. If you’re considering Shed, stick with the injectable and ask which pharmacy is filling your order.

Fridays (8.4): Bundles coaching and labs, but skips the pharmacy disclosure. Fridays markets “503A and 503B certified” partners but does not name them publicly, and per the FDA’s April 2026 clarification compounded semaglutide can currently only come from 503A pharmacies. Where Fridays does stand out: lab work, dietitian access, weekly coaching, and mental health support are all included in every plan tier, with the annual plan landing at $150/month. If pharmacy transparency matters more than coaching depth, OSG, Noom Med, and Henry Meds are stronger picks.

More providers may start being more explicit about their operational quality as buyers demand more about factors like which pharmacy is filling the prescription, the use of semaglutide base or salt, and signed Certificates of Analysis. Whichever provider you go with, you may want to ask for those things in writing. A reputable compounder should have no problem providing them. If a provider hesitates or avoids the question, that’s your answer.

What to Consider When Choosing a Semaglutide Compounding Provider

1. Pharmacy Quality and Accreditation

One of the first things to look at when choosing an online semaglutide compounding provider is the pharmacy that actually compounds the medication. In the U.S., compounded semaglutide generally comes from two types of pharmacies recognized by the Food and Drug Administration (FDA): 503A or 503B pharmacies. 

A 503A pharmacy^[6] is a state-licensed compounding pharmacy that fills prescriptions for individual patients and is regulated by the state board of pharmacy. A 503B facility is a step up, meaning they’re federally registered outsourcing facilities that make larger batches of medication and follow stricter federal manufacturing standards.

You may also come across the term PCAB accreditation^[7], which is a voluntary certification from an independent organization (the Pharmacy Compounding Accreditation Board) that audits compounding pharmacies. If a provider has PCAB accreditation, you can verify it yourself through the ACHC provider directory^[8].

2. API Sourcing and Testing

Another key aspect to review is where the compounding pharmacy sources its active pharmaceutical ingredient (API). 

The semaglutide in FDA-approved Ozempic and Wegovy is semaglutide base (the free peptide form). However, some compounders may be using semaglutide sodium or semaglutide acetate, which are salt forms that may not work the same as the approved form. The FDA has sent warning letters^[5] about how the salt form has not been clinically studied for safety or effectiveness.

Reputable pharmacies should be able to provide a Certificate of Analysis (CoA), which is a third-party report confirming that what’s in your medication matches what’s on the label. Look for the following in the report: 

• Ingredient confirmed as semaglutide base 
• Purity with impurities below 2% 
• Potency matching your labeled dose 
• A lot number tied to your specific batch 
• Testing by an accredited lab (ISO 17025 preferred)

You may want to use caution with a provider that can’t or won’t share which form of semaglutide they use, or if they won’t share a CoA. None of the providers in this guide discusses the salt form publicly, and none publishes a sample CoA. Therefore, you may want to ask each one directly.

3. Level of Clinical Oversight 

Another important factor is how the telehealth platform guides and supervises the handling of prescriptions. On one end, you have required video visits with a licensed clinician who evaluates your overall health history, screens for contraindications, and tracks your treatment response closely. On the other end, you have little more than a quick online form with near-automatic approval.

A trustworthy platform should offer:

• A named, identifiable prescribing physician (not just “licensed providers”)
• Screening for conditions that make semaglutide unsafe for you
• A dosing plan that changes based on your response
• A clear process for reporting side effects or complications

Before you receive your prescription, you may want to ask the following: Whose name is on my prescription? What happens if I report a side effect? Is there a follow-up protocol? If the answers are vague, move on.

4. Transparency and Pricing

Some compounded semaglutide providers have hidden fees or vague terms for auto-renewal. That’s why you’ll want to be sure the provider is transparent about pricing. Before purchasing, verify the following: 

• Does the advertised monthly price match the plan you’re actually signing up for?
• Does the quoted price cover the maintenance dose you’re likely to reach?

Consider prioritizing providers that clearly state their pricing information. If a provider makes it hard to find basic pricing information before you sign up, that could be a sign of what the experience will be like after.

5. Cancellation and Continuity

It’s a good idea to check the provider’s Terms of Service for language on what cancellation entails. 

Before you enroll, find the answers to:

• Can you cancel online, or do you have to call in?
• Are unused prepaid doses refundable if you cancel early?
• How much notice is required to cancel without being charged again?
• What happens to your records and medication supply if the provider pauses operations or shuts down?

That last point is important to look at carefully. Although compounded semaglutide isn’t a controlled substance, there’s no legal barrier to transferring your care to another provider. However, some platforms may make it easier than others to continue care with another provider. 

Why Is Policy Lab Reviewing Affordable Providers?

GLP-1’s and peptides have been a large topic of conversation amongst our user base. With many of our users struggling with conditions associated with metabolic, cardiovascular, and systemic health, alternative treatments are being researched that focus on addressing the underlying cause of issues. With so many questions coming in, we decided to do our own research to help our community find the most cost-effective and trustworthy providers. For more insight into how our research team vets, qualifies, and ranks providers, review our full methodology here.

Frequently Asked Questions

What’s the difference between semaglutide base, sodium, and acetate?

Semaglutide base is the active ingredient in the FDA-approved formulations, Ozempic and Wegovy. Semaglutide sodium and semaglutide acetate are the salt forms, which are chemically different from the active ingredient in the FDA-approved medications. These salt forms have not been studied for safety or effectiveness, and the FDA warns there is no legal basis^[5] for using them in compounded drugs. If a compounded semaglutide provider only offers the base form, find a different provider. 

How is compounded semaglutide different from Ozempic and Wegovy?

The active ingredient in compounded semaglutide is the same molecule that Novo Nordisk sells as Wegovy (FDA-approved for chronic weight management) and Ozempic (FDA-approved for type 2 diabetes, prescribed off-label for weight loss). The difference is not the drug itself. It is how the drug is made, who is allowed to make it, and what regulatory oversight applies.

FDA-approved brand-name products. Wegovy and Ozempic are manufactured by Novo Nordisk under FDA approval. Every batch goes through pharmaceutical-grade manufacturing controls, the labeling is FDA-reviewed, and the dosing matches what was studied in the original clinical trials. The cost without insurance commonly runs $1,000 to $1,350 per month at retail pharmacies. Insurance coverage is the difference between affordable and prohibitively expensive for most patients.

Compounded semaglutide. Compounded versions are prepared by U.S. 503A pharmacies on a patient-specific prescription basis. Compounded products are not FDA-approved, and the FDA has not evaluated them for safety, efficacy, or quality. They are legal under the FDA’s compounding rules when prepared by a state-licensed pharmacy for an identified patient with a documented clinical need. Per the FDA’s April 2026 clarification, a single 503A pharmacy can fill no more than four prescriptions per patient per calendar month, and compounded semaglutide cannot currently be produced by 503B outsourcing facilities because the drug is not on the 503B “bulks list.”

The honest takeaway. If brand-name Wegovy or Ozempic is affordable for you (typically with insurance coverage or a manufacturer savings program), that is the path with the strongest regulatory backing. If compounded is the realistic option, the most important question to ask is not which telehealth platform looks slickest. It is which compounding pharmacy is filling the prescription, and whether that pharmacy meets the basic transparency and accreditation standards described elsewhere on this page.

Can my regular doctor prescribe compounded semaglutide instead of a telehealth service?

Yes, any licensed prescribing doctor or healthcare provider can write a prescription for compounded semaglutide. However, many local primary-care providers don’t have a consistent relationship with compounded pharmacies that prepare GLP-1 products. Therefore, telehealth platforms may be more convenient since they already have a compounding partner and coordinate the prescribing, delivery, and follow-up processes. 

Is compounded tirzepatide a similar alternative to compounded semaglutide?

Compounded tirzepatide may be an alternative to compounded semaglutide. It’s classified as a dual GIP/GLP-1 agonist that has been shown to have stronger effects^[22] on controlling blood sugar and promoting weight loss. The factors used to assess compounded semaglutide providers may also be used to review providers that make compounded tirzepatide. For example, as with semaglutide, only the base form of tirzepatide should be used. 

Can I switch compounded semaglutide providers without starting over?

Yes, it’s possible to switch compounded semaglutide providers since all compounded semaglutide products should contain the same active ingredient. However, the precautions remain the same. In other words, you’ll want to make sure the new compounded semaglutide product comes from a reliable provider. You’ll likely still have to fill out new intake forms and consult the new healthcare provider about continuing the same dose. 

Is compounded semaglutide the same strength as Ozempic or Wegovy?

Compounded semaglutide can be made with the same strength as Ozempic and Wegovy, but it may contain different inactive ingredients. In any case, you’ll want to consult the provider about preparing the dose, since the concentrations of compounded semaglutide products can vary. Before using compounded semaglutide, confirm the concentration (mg/mL) and the dose per injection with the dispensing pharmacy. 

Pharmacy, clinical oversight, and transparency details verified against provider public disclosures and primary-source regulatory references (FDA, USP, PCAB/ACHC, FDA 503B Registered Outsourcing Facilities list, STEP-1^[14] and SUSTAIN^[23] trial publications). Affiliate disclosure: Policy Labs may earn compensation from provider links; rankings and methodology are editorially independent.

Which compounded semaglutide providers don’t require insurance?

None of the providers reviewed on this page require insurance. Compounded semaglutide is sold cash-pay. Telehealth providers handle the prescription, the partner pharmacy fills it, and you pay out of pocket. That structure exists because most insurance plans don’t cover compounded products even when they cover the brand-name equivalents like Wegovy.

Here is what each provider charges as a starting monthly rate without insurance:

• Fridays: $150/mo on the 12-month plan, $175/mo on the 6-month plan, $249/mo month-to-month
• OnlineSemaglutide.org: $142/mo on the 6-month plan, $150/mo on the 3-month plan (with $50-off code policy-lab-50), $249/mo monthly
• Noom Med: $199/mo Microdose plan ($79 first month), $279/mo standard ($129 first month)
• Henry Meds: $197/mo on the 12-month plan, $247/mo on the 6-month plan, $297/mo month-to-month
• Shed: $199/mo starting price, up to $299/mo at higher doses (2-month minimum)

If pricing is your primary filter, Fridays is the lowest sustained per-month rate at $150/mo on the annual plan, and that plan also includes lab work, weekly coaching, and access to dietitians and mental health counselors. On a per-dollar basis, that bundle is hard to beat among the five. The trade-off is a 12-month commitment paid up front to lock in that rate. OnlineSemaglutide.org comes in close on per-month value at $142/mo on the 6-month plan, with no upfront annual commitment.

For buyers who want the lowest entry point rather than the lowest sustained rate, Noom Med’s Microdose plan opens at $79 for the first month and is the cheapest way to try a compounded GLP-1 from a named-leadership provider. All five providers accept HSA and FSA funds where eligible, and FSA/HSA receipts are typically available on request.

Can I get compounded semaglutide without a subscription?

Yes. Three of the five providers reviewed on this page offer a true month-to-month plan: OnlineSemaglutide.org, Henry Meds, and Fridays. You pay for one month at a time, and there is no separate platform fee or membership charge layered on top of the medication price.

Here is how each provider handles month-to-month buyers:

• OnlineSemaglutide.org: Yes. $249/mo standalone monthly plan; multi-month discounts are opt-in.
• Henry Meds: Yes. $297/mo month-to-month plan alongside 6-month and 12-month tiers.
• Fridays: Yes. $249/mo month-to-month with no separate platform fee.
• Noom Med: Partial. Runs on 12-week prescribing cycles (closer to quarterly than monthly).
• Shed: No. Requires a 2-month minimum commitment on the first order.

OnlineSemaglutide.org has the cleanest no-subscription posture on the list. The monthly plan at $249 stands alone, multi-month discounts are positioned as opt-in rather than the default, and pricing is published transparently before you complete the intake. Henry Meds and Fridays both offer real month-to-month plans but lean on multi-month savings to push buyers toward longer commitments.

If avoiding lock-in is your top priority, watch out for two patterns common in this market: “month-to-month” plans that auto-enroll you in multi-month renewal pricing if you don’t cancel within a tight window, and cancellation friction (long hold times, support tickets that go unanswered, refunds tied to terms buried in the fine print). Before paying for any plan, confirm the cancellation method, the refund policy, and the auto-renewal terms in writing.

Sources

1. USP
2. 503B pharmacies
3. FDA’s shortage list
4. 503B bulk drugs list
5. not FDA approved
6. 503A pharmacy
7. PCAB accreditation
8. ACHC provider directory
9. federal charges
10. sterile-compounding problems
11. $56 million
12. BBB reviews
13. clinical trials
14. BBB rating
15. weekly schedule
16. C+ rating
17. thyroid cancer
18. disciplinary actions
19. warning
20. oral semaglutide
21. stronger effects
22. SUSTAIN